Antineuraminidase Antibody Responses in Older Adults After Consecutive Vaccinations With Enhanced Influenza Vaccines: A Randomized Controlled Trial
MF-59 adjuvanted aIIV3 induced superior NAI antibody response in older adults than SD-IIV4 in a 2-year randomized trial.
Authors
- Maryna C. Eichelberger (ORCID: https://orcid.org/0000-0002-3219-4140)
- Malik Peiris (ORCID: https://orcid.org/0000-0001-8217-5995)
- Samuel M. S. Cheng (ORCID: https://orcid.org/0000-0001-7293-2331)
- Hui‐Ling Yen (ORCID: https://orcid.org/0000-0003-2493-3609)
- A. Danielle Iuliano (ORCID: https://orcid.org/0000-0001-8742-3687)
- Yonna W. Y. Leung (ORCID: https://orcid.org/0000-0002-7721-6606)
- Leo L. H. Luk
- Nancy Leung (ORCID: https://orcid.org/0000-0001-7314-840X)
- Benjamin J. Cowling (ORCID: https://orcid.org/0000-0002-6297-7154)
- Pavithra Daulagala (ORCID: https://orcid.org/0000-0003-0303-9413)
- Faith Ho (ORCID: https://orcid.org/0000-0002-5640-2223)
- Jing Lin (ORCID: https://orcid.org/0009-0002-3253-8959)
- Mark G. Thompson (ORCID: https://orcid.org/0000-0003-0046-3147)
- S. Chu
Institutions
- Centers for Disease Control and Prevention (US)
- United States Food and Drug Administration (US)
- Westat (United States) (US)
- Hong Kong Science and Technology Parks Corporation (HK)
- Laboratory of Data Discovery for Health (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1093/infdis/jiaf616
- Citations
- 2
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71